JY
Insider
Jonathan Young
Chief Operating OfficerJonathan Young (Chief Operating Officer) filed 8 Form 4 reports in the past 24 months (0 purchases, 8 sales), most often in AKRO. The largest single filing was $2.2M of AKRO (50,000 sh across 2 lots, as filed), executed Mar 4 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.2M
shares × price, as filed
Last traded
Oct 1 2025
Filed Oct 3 2025
Volume by month
Buys $0
Sells $5.2M
Shares × price, as filed · by filing month · past 24 months
Most traded names
AKRO
AKRO
0 buys · 8 sells
8 filings
Recent filings
AKROSALE
Akero Therapeutics, Inc.
View filing →
$1.6M50,424 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET